# OnCo record patidegib-gel-gorlin-phase-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/patidegib-gel-gorlin-phase-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "patidegib-gel-gorlin-phase-2", "NCT02762084" ;
  schema:name "Patidegib gel in Gorlin syndrome (phase 2A)"@en ;
  schema:alternateName "patidegib topical gel phase 2A"@en ;
  schema:description "People born with Gorlin syndrome grow new basal cell carcinomas for life, and the pills that block the pathway cause side effects most cannot live with. Putting the drug on the skin instead was the obvious idea. A small trial hints that it works, but only in analyses decided after the results were seen."@en ;
  schema:url <https://onco.cc/trials/patidegib-gel-gorlin-phase-2/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02762084>, <https://doi.org/10.1093/bjd/ljae444>, <https://pubmed.ncbi.nlm.nih.gov/39545486/> ;
  onco:status "mixed" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:technologies <https://onco.cc/technologies/hedgehog-inhibitors/> ;
  onco:targets <https://onco.cc/targets/smoothened/> ;
  onco:drugs <https://onco.cc/drugs/patidegib/> ;
  onco:pathways <https://onco.cc/pathways/hedgehog/> ;
  onco:terms <https://onco.cc/terms/hedgehog-inhibitor-tolerability/> ;
  onco:trials <https://onco.cc/trials/erivance/>, <https://onco.cc/trials/stevie/> .